Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
3(21%)
Results Posted
0%(0 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_1
2
14%
Ph phase_4
1
7%
Ph not_applicable
11
79%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
2(14.3%)
Phase 4Post-market surveillance
1(7.1%)
N/ANon-phased studies
11(78.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(3)
Completed(10)
Terminated(1)

Detailed Status

Completed10
Recruiting2
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (14.3%)
Phase 41 (7.1%)
N/A11 (78.6%)

Trials by Status

completed1071%
active_not_recruiting17%
recruiting214%
terminated17%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
14